Recent Advances in Ophthalmic Drug Delivery

• Rein DB , WittenbornJS, ZhangX, HoneycuttAA, LesesneSB, SaaddineJ. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch. Ophthalmol.127(4), 533–540 (2009).
   PubMedGoogle Scholar
• Nowak JZ . Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol. Rep.58(3), 353–363 (2006).
   PubMed Web of Science ®Google Scholar
• VisionGain. World ophthalmic pharmaceutical market 2010–2025. Visiongain Reports (2010).
   Google Scholar
• Cheruvu NP , AmriteAC, KompellaUB. Effect of diabetes on trans-scleral delivery of celecoxib. Pharm. Res.26(2), 404–414 (2009).
   PubMed Web of Science ®Google Scholar
• Amrite AC , EdelhauserHF, SinghSR, KompellaUB. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol. Vis.14, 150–160 (2008).
   PubMed Web of Science ®Google Scholar
• Cheruvu NP , AmriteAC, KompellaUB. Effect of eye pigmentation on trans-scleral drug delivery. Invest. Ophthalmol. Vis. Sci.49(1), 333–341 (2008).
   PubMed Web of Science ®Google Scholar
• Amrite AC , EdelhauserHF, KompellaUB. Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest. Ophthalmol. Vis. Sci.49(1), 320–332 (2008).
   PubMed Web of Science ®Google Scholar
• Kador PF , RandazzoJ, BabbTet al. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts. J. Ocul. Pharmacol. Ther. 23(2), 116–123 (2007).
   PubMed Web of Science ®Google Scholar
• Amrite AC , AyalasomayajulaSP, CheruvuNP, KompellaUB. Single periocular injection of celecoxib-plga microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest. Ophthalmol. Vis. Sci.47(3), 1149–1160 (2006).
   PubMed Web of Science ®Google Scholar
• Ayalasomayajula SP , KompellaUB. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. Eur. J. Pharmacol.511(2–3), 191–198 (2005).
   PubMed Web of Science ®Google Scholar
• Ayalasomayajula SP , KompellaUB. Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared with systemic administration. Pharm. Res.21(10), 1797–1804 (2004).
   PubMed Web of Science ®Google Scholar
• Koushik K , KompellaUB. Preparation of large porous deslorelin-plga microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process. Pharm. Res.21(3), 524–535 (2004).
   PubMed Web of Science ®Google Scholar
• Sunkara G , AyalasomayajulaSP, RaoCS, VennerstromJL, DeruiterJ, KompellaUB. Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor. J. Pharm. Pharmacol.56(3), 351–358 (2004).
   PubMed Web of Science ®Google Scholar
• Aukunuru JV , SunkaraG, AyalasomayajulaSP, DeruiterJ, ClarkRC, KompellaUB. A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications. Pharm. Res.19(3), 278–285 (2002).
   PubMed Web of Science ®Google Scholar
• Proksch JW , GranvilCP, Siou-MermetR, ComstockTL, PaternoMR, WardKW. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. J. Ocul. Pharmacol. Ther.25(4), 335–344 (2009).
   PubMed Web of Science ®Google Scholar
• Lee VH , RobinsonJR. Topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol.2(1), 67–108 (1986).
   PubMedGoogle Scholar
• Macha S , MitraAK. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp. Eye Res.72(3), 289–299 (2001).
   PubMed Web of Science ®Google Scholar
• Macha S , DuvvuriS, MitraAK. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Curr. Eye. Res.28(2), 77–84 (2004).
   PubMed Web of Science ®Google Scholar
• Dias CS , MitraAK. Posterior segment ocular pharmacokinetics using microdialysis in a conscious rabbit model. Invest. Ophthalmol. Vis. Sci.44(1), 300–305 (2003).
   PubMed Web of Science ®Google Scholar
• Rittenhouse KD , PeifferRL Jr, Pollack GM. Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J. Pharm. Biomed. Anal.16(6), 951–959 (1998).
   PubMed Web of Science ®Google Scholar
• Pearson PA , JaffeGJ, MartinDFet al. Evaluation of a delivery system providing long-term release of cyclosporine. Arch. Ophthalmol. 114(3), 311–317 (1996).
   PubMed Web of Science ®Google Scholar
• Acheampong AA , ShackletonM, Tang-LiuDD, DingS, SternME, DeckerR. Distribution of cyclosporin a in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr. Eye Res.18(2), 91–103 (1999).
   PubMed Web of Science ®Google Scholar
• Wei G , XuH, DingPT, LiSM, ZhengJM. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and g scintigraphic studies. J. Control. Release83(1), 65–74 (2002).
   PubMed Web of Science ®Google Scholar
• Klyce SD , CrossonCE. Transport processes across the rabbit corneal epithelium: a review. Curr. Eye Res.4(4), 323–331 (1985).
   PubMed Web of Science ®Google Scholar
• Kompella UB , KimKJ, LeeVH. Active chloride transport in the pigmented rabbit conjunctiva. Curr. Eye Res.12(12), 1041–1048 (1993).
   PubMed Web of Science ®Google Scholar
• Wang W , SasakiH, ChienDS, LeeVH. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr. Eye Res.10(6), 571–579 (1991).
   PubMed Web of Science ®Google Scholar
• Raghava S , HammondM, KompellaUB. Periocular routes for retinal drug delivery. Expert Opin. Drug Deliv.1(1), 99–114 (2004).
   PubMedGoogle Scholar
• Rao VR , PrescottE, ShelkeNBet al. Delivery of SAR 1118 to retina via ophthalmic drops and its effectiveness in reduction of retinal leukostasis and vascular leakiness in rat streptozotocin (STZ) model of diabetic retinopathy (DR). Invest. Ophthalmol. Vis. Sci. doi:10.1167/iovs.09-5144 (2010) (Epub ahead of print).
   Web of Science ®Google Scholar
• Hariprasad SM , MielerWF, HolzER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch. Ophthalmol.121(3), 345–350 (2003).
   PubMedGoogle Scholar
• Olsen TW , FengX, WabnerKet al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am. J. Ophthalmol. 142(5), 777–787 (2006).
   PubMed Web of Science ®Google Scholar
• Felt O , FurrerP, MayerJM, PlazonnetB, BuriP, GurnyR. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm.180(2), 185–193 (1999).
   PubMed Web of Science ®Google Scholar
• Meseguer G , GurnyR, BuriP, RozierA, PlazonnetB. γ scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine. Int. J. Pharm.95, 229–234 (1993).
   Web of Science ®Google Scholar
• Yamamura K , SasakiH, NakashimaMet al. Characterization of ocular pharmacokinetics of β-blockers using a diffusion model after instillation. Pharm. Res. 16(10), 1596–1601 (1999).
   PubMed Web of Science ®Google Scholar
• Akpek EK , VittitowJ, VerhoevenRSet al. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation. J. Ocul. Pharmacol. Ther. 25(5), 433–439 (2009).
   PubMed Web of Science ®Google Scholar
• Hornof MD , Bernkop-SchnurchA. In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits. J. Pharm. Sci.91(12), 2588–2592 (2002).
   PubMed Web of Science ®Google Scholar
• Maurice D . The effect of the low blink rate in rabbits on topical drug penetration. J. Ocul. Pharmacol. Ther.11(3), 297–304 (1995).
   PubMed Web of Science ®Google Scholar
• Witcherle O , LimD. Hydrophilic gels for biological use. Nature185, 117–118 (1960).
   Web of Science ®Google Scholar
• Lim L , LoughnanMS, SullivanLJ. Microbial keratitis associated with extended wear of silicone hydrogel contact lenses. Br. J. Ophthalmol.86(3), 355–357 (2002).
   PubMed Web of Science ®Google Scholar
• Hehl EM , BeckR, LuthardK, GuthoffR, DrewelowB. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of acuvue contact lenses. Eur. J. Clin. Pharmacol.55(4), 317–323 (1999).
   PubMed Web of Science ®Google Scholar
• Sedlacek J . Possibility of the application of ophthalmic drugs with the use of gel contact lenses. Cesk. Oftalmol.21(6), 509–512 (1965).
   PubMedGoogle Scholar
• Karlgard CC , JonesLW, MoresoliC. Ciprofloxacin interaction with silicon-based and conventional hydrogel contact lenses. Eye Contact Lens29(2), 83–89 (2003).
   PubMedGoogle Scholar
• Karlgard CC , WongNS, JonesLW, MoresoliC. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-hema hydrogel contact lens materials. Int. J. Pharm.257(1–2), 141–151 (2003).
   PubMed Web of Science ®Google Scholar
• Kim J , ConwayA, ChauhanA. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials29(14), 2259–2269 (2008).
   PubMed Web of Science ®Google Scholar
• Haugen B , WernerL, RomanivNet al. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis. J. Cataract Refract. Surg. 34(5), 853–858 (2008).
   PubMed Web of Science ®Google Scholar
• Hiratani H , Alvarez-LorenzoC. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J. Control. Release83(2), 223–230 (2002).
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C , YanezF, Barreiro-IglesiasR, ConcheiroA. Imprinted soft contact lenses as norfloxacin delivery systems. J. Control. Release113(3), 236–244 (2006).
   PubMed Web of Science ®Google Scholar
• Ali M , HorikawaS, VenkateshS, SahaJ, HongJW, ByrneME. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J. Control. Release124(3), 154–162 (2007).
   PubMed Web of Science ®Google Scholar
• Danion A , BrochuH, MartinY, VermetteP. Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes. J. Biomed. Mater. Res. A82(1), 41–51 (2007).
   PubMed Web of Science ®Google Scholar
• Danion A , ArsenaultI, VermetteP. Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin. J. Pharm. Sci.96(9), 2350–2363 (2007).
   PubMed Web of Science ®Google Scholar
• Ciolino JB , HoareTR, IwataNGet al. A drug-eluting contact lens. Invest. Ophthalmol. Vis. Sci. 50(7), 3346–3352 (2009).
   PubMed Web of Science ®Google Scholar
• Sano K , TokoroT, ImaiY. A new drug delivery system utilizing piggyback contact lenses. Acta. Ophthalmol. Scand.74(3), 243–248 (1996).
   PubMedGoogle Scholar
• Gulsen D , ChauhanA. Dispersion of microemulsion drops in hema hydrogel: a potential ophthalmic drug delivery vehicle. Int. J. Pharm.292(1–2), 95–117 (2005).
   PubMed Web of Science ®Google Scholar
• Gulsen D , LiCC, ChauhanA. Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. Curr. Eye Res.30(12), 1071–1080 (2005).
   PubMed Web of Science ®Google Scholar
• Gulsen D , ChauhanA. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci.45(7), 2342–2347 (2004).
   PubMed Web of Science ®Google Scholar
• Kapoor Y , ThomasJC, TanG, JohnVT, ChauhanA. Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs. Biomaterials30(5), 867–878 (2009).
   PubMed Web of Science ®Google Scholar
• Lim M , JacobsDS, RosenthalP, CarrasquilloKG. The boston ocular surface prosthesis as a novel drug delivery system for bevacizumab. Seminars in Ophthalmology24(3), 149–155 (2009).
   PubMed Web of Science ®Google Scholar
• Kim SW , HaBJ, KimEK, TchahH, KimTI. The effect of topical bevacizumab on corneal neovascularization. Ophthalmology115(6), e33–38 (2008).
   PubMedGoogle Scholar
• Ottiger M , ThielMA, FeigeU, LichtlenP, UrechDM. Efficient intraocular penetration of topical anti-TNF-α single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer. Invest. Ophthalmol. Vis. Sci.50(2), 779–786 (2009).
   PubMed Web of Science ®Google Scholar
• Calonge M . The treatment of dry eye. Surv. Ophthalmol.45(Suppl. 2), S227–S239 (2001).
   PubMed Web of Science ®Google Scholar
• Balaram M , SchaumbergDA, DanaMR. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am. J. Ophthalmol.131(1), 30–36 (2001).
   PubMed Web of Science ®Google Scholar
• Wei CP , AndersonJA, LeopoldI. Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine. Invest. Ophthalmol. Vis. Sci.17(4), 315–321 (1978).
   PubMed Web of Science ®Google Scholar
• Kass MA , MandellAI, GoldbergI, PaineJM, BeckerB. Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study. Arch. Ophthalmol.97(10), 1865–1866 (1979).
   PubMedGoogle Scholar
• Rautio J , KumpulainenH, HeimbachTet al. Prodrugs: design and clinical applications. Nat. Rev. Drug Discov. 7(3), 255–270 (2008).
   PubMed Web of Science ®Google Scholar
• Hellberg MR , KeTL, HaggardK, KlimkoPG, DeanTR, GraffG. The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor pgf2a by human and rabbit ocular tissue. J. Ocul. Pharmacol. Ther.19(2), 97–103 (2003).
   PubMed Web of Science ®Google Scholar
• Netland PA , LandryT, SullivanEKet al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am. J. Ophthalmol. 132(4), 472–484 (2001).
   PubMed Web of Science ®Google Scholar
• Susanna R Jr, Chew P, Kitazawa Y. Current status of prostaglandin therapy: latanoprost and unoprostone. Surv. Ophthalmol.47(Suppl. 1), S97-S104 (2002).
   PubMedGoogle Scholar
• Lallemand F , PerottetP, Felt-BaeyensOet al. A water-soluble prodrug of cyclosporine a for ocular application: a stability study. Eur. J. Pharm. Sci. 26(1), 124–129 (2005).
   PubMed Web of Science ®Google Scholar
• Lallemand F , Felt-BaeyensO, RudazSet al. Conversion of cyclosporine a prodrugs in human tears vs rabbits tears. Eur. J. Pharm. Biopharm. 59(1), 51–56 (2005).
   PubMed Web of Science ®Google Scholar
• Liu H , WangY, LiS. Advanced delivery of ciclosporin a: present state and perspective. Expert Opin. Drug Deliv.4(4), 349–358 (2007).
   PubMed Web of Science ®Google Scholar
• Olivero DK , DavidsonMG, EnglishRV, NasisseMP, JamiesonVE, GerigTM. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. J. Am. Vet. Med. Assoc.199(8), 1039–1042 (1991).
   PubMed Web of Science ®Google Scholar
• Benitez Del Castillo JM , Del Aguila C, Duran S, Hernandez J, Garcia Sanchez J. Influence of topically applied cyclosporine a in olive oil on corneal epithelium permeability. Cornea13(2), 136–140 (1994).
   PubMed Web of Science ®Google Scholar
• Bourges JL , LallemandF, AglaEet al. Evaluation of a topical cyclosporine a prodrug on corneal graft rejection in rats. Mol. Vis. 12, 1461–1466 (2006).
   PubMed Web of Science ®Google Scholar
• Dey S , AnandBS, PatelJ, MitraAK. Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies. Expert Opin. Biol. Ther.3(1), 23–44 (2003).
   PubMed Web of Science ®Google Scholar
• Janoria KG , GundaS, BodduSH, MitraAK. Novel approaches to retinal drug delivery. Expert Opin. Drug Deliv.4(4), 371–388 (2007).
   PubMed Web of Science ®Google Scholar
• Hosoya K , TachikawaM. Inner blood-retinal barrier transporters: role of retinal drug delivery. Pharm. Res.26(9), 2055–2065 (2009).
   PubMed Web of Science ®Google Scholar
• Ueda H , HoribeY, KimKJ, LeeVH. Functional characterization of organic cation drug transport in the pigmented rabbit conjunctiva. Invest. Ophthalmol. Vis. Sci.41(3), 870–876 (2000).
   PubMed Web of Science ®Google Scholar
• Karla PK , PalD, MitraAK. Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells. Exp. Eye Res.84(1), 53–60 (2007).
   PubMed Web of Science ®Google Scholar
• Mannermaa E , VellonenKS, RyhanenTet al. Efflux protein expression in human retinal pigment epithelium cell lines. Pharm. Res. 26(7), 1785–1791 (2009).
   PubMed Web of Science ®Google Scholar
• Prasanna G , FortnerJ, XiangCet al. Ocular pharmacokinetics and hypotensive activity of pf-04475270, an ep4 prostaglandin agonist in preclinical models. Exp. Eye Res. 89(5), 608–617 (2009).
   PubMed Web of Science ®Google Scholar
• Gehlbach P , DemetriadesAM, YamamotoSet al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 10(8), 637–646 (2003).
   PubMed Web of Science ®Google Scholar
• Kompella UB , SundaramS, RaghavaS, EscobarER. Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model. Mol. Vis.12, 1185–1198 (2006).
   PubMed Web of Science ®Google Scholar
• Loftssona T , JarvinenT. Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev.36(1), 59–79 (1999).
   PubMed Web of Science ®Google Scholar
• Stefansson E , LoftssonaT. Cyclodextrins in eye drop formulations. J. Incl. Phenomena Macrocyclic Chem.44, 23–27 (2002).
   Web of Science ®Google Scholar
• Bary AR , TuckerIG, DaviesNM. Considerations in the use of hydroxypropyl-β-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone. Eur. J. Pharm. Biopharm.50(2), 237–244 (2000).
   PubMed Web of Science ®Google Scholar
• Loftsson T , FrithriksdottirH, StefanssonE, ThorisdottirS, GuthmundssonO, SigthorssonT. Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J. Pharm. Pharmacol.46(6), 503–504 (1994).
   PubMed Web of Science ®Google Scholar
• Cheeks L , KaswanRL, GreenK. Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea. Curr. Eye Res.11(7), 641–649 (1992).
   PubMed Web of Science ®Google Scholar
• Loftsson T , FridriksdottirH, ThorisdottirS, StefanssonE. The effect of hydroxypropyl methylcellulose on release of dexamethazone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. Int. J. Pharm.104, 181–184 (1994).
   Web of Science ®Google Scholar
• Kristinsson JK , FridriksdottirH, ThorisdottirS, SigurdardottirAM, StefanssonE, LoftssonT. Dexamethasone–cyclodextrin–polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest. Ophthalmol. Vis. Sci.37(6), 1199–1203 (1996).
   PubMed Web of Science ®Google Scholar
• Ashton P , PodderSK, LeeVH. Formulation influence on conjunctival penetration of four b blockers in the pigmented rabbit: a comparison with corneal penetration. Pharm. Res.8(9), 1166–1174 (1991).
   PubMed Web of Science ®Google Scholar
• Lee YH , LeeVH. Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit. J. Ocul. Pharmacol.9(1), 47–58 (1993).
   PubMedGoogle Scholar
• Scholz M , LinJE, LeeVH, KeipertS. Pilocarpine permeability across ocular tissues and cell cultures: influence of formulation parameters. J. Ocul. Pharmacol. Ther.18(5), 455–468 (2002).
   PubMed Web of Science ®Google Scholar
• Lee VH , YamamotoA, KompellaUB. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Syst.8(2), 91–192 (1991).
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E , DombAJ. Iontophoresis: a noninvasive ocular drug delivery. J. Control. Release110(3), 479–489 (2006).
   PubMed Web of Science ®Google Scholar
• Nurieva SM . [Effect on the eye vessels of vasodilator agents after their administration by different electrophoretic methods (clinical study)]. Vestn. Oftalmol.(2), 71–73 (1978).
   Google Scholar
• Polunin GS , Kas‘ianovaNS. [Fluorophotometry in the clinical aspects of eye diseases]. Vestn. Oftalmol.(5), 52–57 (1979).
   Google Scholar
• Bourne WM , BrubakerRF. Decreased endothelial permeability in the iridocorneal endothelial syndrome. Ophthalmology89(6), 591–595 (1982).
   PubMed Web of Science ®Google Scholar
• Maurice DM . Iontophoresis of fluorescein into the posterior segment of the rabbit eye. Ophthalmology93(1), 128–132 (1986).
   PubMed Web of Science ®Google Scholar
• Meyer DR , LinbergJV, VasquezRJ. Iontophoresis for eyelid anesthesia. Ophthalmic Surg21(12), 845–848 (1990).
   PubMedGoogle Scholar
• Horwath-Winter J , SchmutO, Haller-SchoberEM, GruberA, RiegerG. Iodide iontophoresis as a treatment for dry eye syndrome. Br. J. Ophthalmol.89(1), 40–44 (2005).
   PubMed Web of Science ®Google Scholar
• Parkinson TM , FergusonE, FebbraroS, BakhtyariA, KingM, MundasadM. Tolerance of ocular iontophoresis in healthy volunteers. J. Ocul. Pharmacol. Ther.19(2), 145–151 (2003).
   PubMed Web of Science ®Google Scholar
• Amrite A , PugazhenthiV, CheruvuN, KompellaU. Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes. Expert Opin. Drug Deliv.7(5), 631–645 (2010).
   PubMed Web of Science ®Google Scholar
• Prausnitz MR , NoonanJS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci.87(12), 1479–1488 (1998).
   PubMed Web of Science ®Google Scholar
• Kim TW , LindseyJD, AiharaM, AnthonyTL, WeinrebRN. Intraocular distribution of 70-kda dextran after subconjunctival injection in mice. Invest. Ophthalmol. Vis. Sci.43(6), 1809–1816 (2002).
   PubMed Web of Science ®Google Scholar
• Cheruvu NP , KompellaUB. Bovine and porcine trans-scleral solute transport: influence of lipophilicity and the choroid-bruch‘s layer. Invest. Ophthalmol. Vis. Sci.47(10), 4513–4522 (2006).
   PubMed Web of Science ®Google Scholar
• Kadam RS , KompellaUB. Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve. J. Pharmacol. Exp. Ther.332(3), 1107–1120 (2010).
   PubMed Web of Science ®Google Scholar
• Durairaj C , ShahJC, SenapatiS, KompellaUB. Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure–pharmacokinetic relationships (QSPKR). Pharm. Res.26(5), 1236–1260 (2009).
   PubMed Web of Science ®Google Scholar
• Durairaj C , KimSJ, EdelhauserHF, ShahJC, KompellaUB. Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest. Ophthalmol. Vis. Sci.50(10), 4887–4897 (2009).
   PubMed Web of Science ®Google Scholar
• Danis RP , CiullaTA, PrattLM, AnlikerW. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina20(3), 244–250 (2000).
   PubMed Web of Science ®Google Scholar
• Jonas JB , KreissigI, SofkerA, DegenringRF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch. Ophthalmol.121(1), 57–61 (2003).
   PubMed Web of Science ®Google Scholar
• Jonas JB . Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res.38(4), 218–245 (2006).
   PubMed Web of Science ®Google Scholar
• Mason JO 3rd, Somaiya MD, Singh RJ. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina24(6), 900–904 (2004).
   PubMed Web of Science ®Google Scholar
• Chin HS , ParkTS, MoonYS, OhJH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina25(5), 556–560 (2005).
   PubMed Web of Science ®Google Scholar
• Choonara YE , PillayV, DanckwertsMP, CarmichaelTR, Du Toit LC. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J. Pharm. Sci.99(5), 2219–2239 (2009).
   Web of Science ®Google Scholar
• Short BG . Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol. Pathol.36(1), 49–62 (2008).
   PubMed Web of Science ®Google Scholar
• Bourges JL , BloquelC, ThomasAet al. Intraocular implants for extended drug delivery: therapeutic applications. Adv. Drug Deliv. Rev. 58(11), 1182–1202 (2006).
   PubMed Web of Science ®Google Scholar
• Ramchandran RS , FekratS, StinnettSS, JaffeGJ. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am. J. Ophthalmol.146(2), 285–291 (2008).
   PubMed Web of Science ®Google Scholar
• Ayalasomayajula SP , AshtonP, KompellaUB. Fluocinolone inhibits vegf expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-α-induced angiogenesis in chick chorioallantoic membrane (CAM). J. Ocul. Pharmacol. Ther.25(2), 97–103 (2009).
   PubMed Web of Science ®Google Scholar
• Del Amo EM , UrttiA. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov. Today13(3–4), 135–143 (2008).
   PubMed Web of Science ®Google Scholar
• Kompella UB , LiX, ZhanG, LeeSS. Influence of intravitreal implant location on ocular disposition of fluocinolone acetonide. ARVO Annual Meeting 5971/A5594 (2009).
   Google Scholar
• Novack GD . Ophthalmic drug delivery: development and regulatory considerations. Clin. Pharmacol. Ther.85(5), 539–543 (2009).
   PubMed Web of Science ®Google Scholar
• Rieke ER , AmaralJ, Patricia Becerra S, Lutz RJ. Sustained subconjunctival protein delivery using a thermosetting gel delivery system. J. Ocul. Pharmacol. Ther. (2010) (In Press).
   PubMedGoogle Scholar
• Kim EY , GaoZG, ParkJS, LiH, HanK. RHEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery. Int. J. Pharm.233(1–2), 159–167 (2002).
   PubMed Web of Science ®Google Scholar
• Kompella UB , BandiN, AyalasomayajulaSP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest. Ophthalmol. Vis. Sci.44(3), 1192–1201 (2003).
   PubMed Web of Science ®Google Scholar
• Kang SJ , DurairajC, KompellaUB, O‘BrienJM, GrossniklausHE. Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma. Arch. Ophthalmol.127(8), 1043–1047 (2009).
   PubMed Web of Science ®Google Scholar
• Chiang CH , TungSM, LuDW, YehMK. In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres. J. Ocul. Pharmacol. Ther.17(6), 545–553 (2001).
   PubMed Web of Science ®Google Scholar
• Van Quill KR , DioguardiPK, TongCTet al. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology 112(6), 1151–1158 (2005).
   PubMed Web of Science ®Google Scholar
• Saishin Y , SilvaRL, SaishinYet al. Periocular injection of microspheres containing pkc412 inhibits choroidal neovascularization in a porcine model. Invest. Ophthalmol. Vis. Sci. 44(11), 4989–4993 (2003).
   PubMed Web of Science ®Google Scholar
• Sunkara G , KompellaUB. Membrane transport processes in the eye. In: Ophthalmic Drug Delivery Systems, Mitra AK (Ed.). Marcel Dekker Inc., NY, USA, 13–58 (2003).
   Google Scholar

Patent

• Bowman LM, Roy S, Pens S. Topical treatment for prevention of ocular infections. WO019366 (2001).
   Google Scholar
• Nakada K, Sugiyama A. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced. US6027745 (1998).
   Google Scholar
• Rosenthal P, Jacobs D. Drug delivery systems with scleral lens. US0286338 (2008).
   Google Scholar
• Borgia MJ, Chaouk H, Cui H, Laredo W, Li Z, Nathan A. Punctal plugs for the delivery of active agents. US0045911 (2008).
   Google Scholar
• Rodstrom T, Smith L, Tian Y, Marsh D, Weiner A, Bakshi S. Punctal plugs and methods of delivering therapeutic agents. WO094989 (2008)
   Google Scholar
• Chauhan A, Hens Z. Dry eye treatment by punctal plug. WO079559 (2009)
   Google Scholar

Websites

• Punctal plugs and moisture treatment in dry eye treatment – the eye digest www.agingeye.net/dryeyes/plugsetc.php
   Google Scholar
• QLT Inc. www.qltinc.com
   Google Scholar